| Ticker Details |
|
Centessa Pharmaceuticals plc
|
| IPO Date: |
May 28, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$3.62B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.36 | 3.32%
|
| Avg Daily Range (30 D): |
$0.46 | 1.91%
|
| Avg Daily Range (90 D): |
$0.54 | 2.25%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.43M |
| Avg Daily Volume (30 D): |
1.27M |
| Avg Daily Volume (90 D): |
1.39M |
| Trade Size |
| Avg Trade Size (Sh.): |
113 |
| Avg Trade Size (Sh.) (30 D): |
110 |
| Avg Trade Size (Sh.) (90 D): |
100 |
| Institutional Trades |
| Total Institutional Trades: |
1,136 |
| Avg Institutional Trade: |
$1.68M |
| Avg Institutional Trade (30 D): |
$3.33M |
| Avg Institutional Trade (90 D): |
$2.14M |
| Avg Institutional Trade Volume: |
.1M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.4M |
| Avg Closing Trade (30 D): |
$1.64M |
| Avg Closing Trade (90 D): |
$1.88M |
| Avg Closing Volume: |
68.12K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.9
|
$-.41
|
$-.38
|
|
Diluted EPS
|
$-1.9
|
$-.41
|
$-.38
|
|
Revenue
|
$15M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-242.7M
|
$-54.89M
|
$-50.34M
|
|
Operating Income / Loss
|
$-213.8M
|
$-53.79M
|
$-54.65M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-344.22M
|
$6.57M
|
$-60.91M
|
|
PE Ratio
|
|
|
|
|
|
|